CARM1 and neoplasm: We further tested the effect of CARM1 and GATAD2A on tumor growth in vivo by injecting nude mice subcutaneously with control MCF7 cells or cells infected with shRNA targeting CARM1 or GATAD2A, and then treated with estrogen to stimulate tumor growth.